Apr 21, 2016

India Patent Office Decision Denying Cipla's Patent Application for an Anti-Retroviral Combination

This post examines the April 1, 2016 decision issued by the Indian Patent Office involving patent application 1399/MUMNP/2010 entitled, "Anti-retroviral Combination", (the '1399 application) owned by Cipla Limited. The '1399 application was filed on June 30, 2010, and claims a pharmaceutical composition for treating HIV comprising ritonavir and darunavir. The application was filed with the […]
back to top